#AANAM – Tysabri Improves Quality of Life, Can Reduce Infection Risk

#AANAM – Tysabri Improves Quality of Life, Can Reduce Infection Risk

292684

#AANAM – Tysabri Improves Quality of Life, Can Reduce Infection Risk

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. Treatment with Tysabri (natalizumab) can improve mental and social health in people with multiple sclerosis (MS), according to new data presented at the 2021 virtual American Academy of Neurology annual meeting (AANAM). Data presented at AANAM also indicate that less frequent dosing of Tysabri can reduce the risk of…

You must be logged in to read/download the full post.